Research indicates that CYP27A1 overexpression promotes 27-HC production and significantly suppresses bladder cancer cell growth (78), suggesting that CYP27A1 overexpression may represent a potential therapeutic strategy for bladder cancer. This evidence concerns the gene CYP27A1 and urinary bladder carcinoma.